A new clinical trial sponsored by the University Health Network in Toronto is presently recruiting patients with prostate cancer for a prospective study aimed at evaluating the effect of preoperative treatment with topical Brimonidine Tartrate on ontraocular pressure. For patients undergoing robot-assisted laparoscopic prostatectomy, the goal of this trial is to prevent "intraocular pressure spike thereby reducing risk of postperative vision loss."
To read more about this trial, click here.
No comments:
Post a Comment